0 items USD 0.00Search
Your search for "current partnering global merger acquisition terms agreements pharma biotech 1" gave back 1512602 results.
Highlights The global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory Market The global Pharma and Biotech...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The “Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses...
Catalog:
La Merie Publishing
January 2017
Price: USD 2,400.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
Catalog:
La Merie Publishing
January 2018
Price: USD 2,800.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
The global Hepatocyte Growth Factor market size was valued at USD 46 million in 2023 and is forecast to a readjusted size of USD 271 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The report entitled „Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the...
Catalog:
La Merie Publishing
January 2014
Price: USD 2,298.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug...
Catalog:
La Merie Publishing
February 2016
Price: USD 1,050.00
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
Catalog:
La Merie Publishing
August 2023
Price: USD 2,365.00
Fibroblast Growth Factor 2 - Pipeline Review, H2 2019 Summary According to the recently published report 'Fibroblast Growth Factor 2 - Pipeline...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
